 |
 |

L-ARTERENOL (LEVOPHED®) IN THE TREATMENT OF SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION
ALBERT J. MILLER, M.D.;
LYLE A. BAKER, M.D.
AMA Arch Intern Med. 1952;89(4):591-599.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
THE OCCURRENCE of severe shock following myocardial infarction has generally been considered of such grave prognostic import as almost to negate the possibility of effective therapy. It remains true that shock is a grave prognostic indication, but it is encouraging to find more investigators directing their attention to a reasonable therapeutic approach. Inasmuch as the degree of shock is not necessarily in direct proportion to the size of the infarct, it is not unlikely that the resolution of the shock state could lead to recovery in a proportion of the patients who now succumb.
Rosenbaum and Levine1 reported a 51% mortality rate for cases of infarction complicated by moderate shock and a 93% mortality for those with severe shock. They considered the prognosis grave if the blood pressure remained at 80 mm. Hg or less for any length of time. Katz and Mintz2 found that a systolic blood
. . . [Full Text PDF of this Article]
Author Affiliations
CHICAGO; HINES, ILL.
From the Medical Service, Veterans Administration Hospital.
Footnotes
Dr. Miller was formerly a Resident in Medicine at the Veterans Administration Hospital, Hines, I11.
Reviewed in the Veterans Administration and published with the approval of the Chief Medical Director. The statements and conclusions published by the authors are the result of their own study and do not necessarily reflect the opinion or policy of the Veterans Administration.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|